SOMATULINE DEPOT: payments to doctors
Payments that named SOMATULINE DEPOT as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $2.3M
- Providers
- 7,265
- Transactions
- 19,025
- Average per transaction
- $120
The per-transaction average — $120 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 7,265 providers the average total is $314, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Ipsen Biopharmaceuticals, Inc | $2,224,920 | 97.6% |
| Ipsen Innovation | $36,577 | 1.6% |
| Ipsen Biopharm Limited | $9,090 | 0.4% |
| Ipsen Pharma SAS | $8,670 | 0.4% |
| Epizyme, Inc. | $99 | 0.0% |